DUBLIN, Aug. 3, 2022 /PRNewswire/ -- The "Global Next Generation Sequencing Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global next generation sequencing market is expected to grow from $8.05 billion in 2021 to $9.22 billion in 2022 at a compound annual growth rate (CAGR) of 14.4%. The market is expected to grow to $15.21 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%.
North America was the largest region in the next-generation sequencing market in 2021. Asia Pacific was the second largest region in the next-generation sequencing market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The growing number of cases with chronic conditions such as cancer, AIDS, and thalassemia contributed to the growth of the next-generation sequencing market. Chronic illnesses and disorders are on the rise around the world, an aging population and shifts in social behavior lead to a gradual increase in these widespread and expensive long-term medical issues.
Next-generation sequencing (NGS) is a versatile development tool utilized by researchers and clinicians across various cancer studies to recognize biomarkers that give guidance on treatments. The prevalence of chronic diseases is also expected to increase significantly, according to the World Health Organization. Hence, the increase in the number of chronic disease cases will increase the requirement for NGS sequencing and boosts revenues for the next-generation sequencing market.
The high cost associated with next-generation sequencing technologies is a key factor hampering the growth of the next-generation sequencing market. The next-generation sequencing market is facing challenges as many people find it difficult to afford the test due to the high cost. Consumables used for sequencing are the costliest portion of testing (68-72% of total cost) as machinery prices are higher in instances of rare disease.
According to a review published on economic evaluations of exome and genome sequencing, the cost of next-generation genome sequencing ranges from $1906 to $24,810 for a single test. Therefore, the high cost of next-generation sequencing is anticipated to restrict market growth over the forecast period.
Technological advances are shaping the next-generation sequencing market. Major companies operating in the sequencing industry are focusing on developing technologically advanced solutions for next-generation sequencing. For instance, in 2020, Thermo Fisher Scientific introduced hematology-oncology assays for the Ion Torrent Genexus System, which authorize simultaneous analysis of DNA mutations and RNA fusion transcripts in myeloid samples in a single day and also enabled further in which turnaround times for next-generation sequencing (NGS) results could be reduced to less than 24 hours.
Markets Covered:
1) By Product: NextSeq Systems; MiniSeq Systems; NovaSeq Systems; iSeq 100 Systems; Ion PGM Systems; Ion Proton Systems; Ion GeneStudio S5 Systems; PacBio RS II Systems; Sequel Systems; Other Products
2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
3) By Application: Diagnostics; Drug Discovery; Other Applications
Key Topics Covered:
1. Executive Summary
2. Next Generation Sequencing Market Characteristics
3. Next Generation Sequencing Market Trends And Strategies
4. Impact Of COVID-19 On Next Generation Sequencing
5. Next Generation Sequencing Market Size And Growth
6. Next Generation Sequencing Market Segmentation
7. Next Generation Sequencing Market Regional And Country Analysis
8. Asia-Pacific Next Generation Sequencing Market
9. China Next Generation Sequencing Market
10. India Next Generation Sequencing Market
11. Japan Next Generation Sequencing Market
12. Australia Next Generation Sequencing Market
13. Indonesia Next Generation Sequencing Market
14. South Korea Next Generation Sequencing Market
15. Western Europe Next Generation Sequencing Market
16. UK Next Generation Sequencing Market
17. Germany Next Generation Sequencing Market
18. France Next Generation Sequencing Market
19. Eastern Europe Next Generation Sequencing Market
20. Russia Next Generation Sequencing Market
21. North America Next Generation Sequencing Market
22. USA Next Generation Sequencing Market
23. South America Next Generation Sequencing Market
24. Brazil Next Generation Sequencing Market
25. Middle East Next Generation Sequencing Market
26. Africa Next Generation Sequencing Market
27. Next Generation Sequencing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Next Generation Sequencing Market
29. Next Generation Sequencing Market Future Outlook and Potential Analysis
30. Appendix
Companies Mentioned
- Illumina Inc.
- Thermo Fisher Scientific inc.
- BGI Group
- Agilent Technologies Inc.
- Qiagen N.V.
- Hoffmann-La Roche AG
- Eurofins Scientific
- Oxford Nanopore Technologies
- Pacific Biosciences
- 10x Genomics
- Genomatix GmbH
- PierianDx
- Bio-Rad Laboratories Inc.
- Roche Sequencing
- NanoString
- Genapsys
- Long Read Solutions
- LGC Limited
- 454 Life Sciences Corporation (Roche Holding AG)
- Genewiz
- Takara Bio
- Nugen Technologies
For more information about this report visit https://www.researchandmarkets.com/r/h8p05t
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article